Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Helal Egyptian Liver Journal .2025;[Epub] CrossRef Evaluation of triponderal mass index in predicting metabolic associated fatty liver disease in obese children Yavuz zer, Ersin Ulu, Emine Yurdakul Ertrk Pediatrics International .2025;[Epub] CrossRef Serum complement C3 as a diagnostic biomarker for metabolic dysfunction -associated steatotic liver disease in middle-aged and elderly adults: a cross-sectional study Dan Ye, Haifen Ma, Jingjing Zhou, Jiaofeng Wang, Jiaheng Shi, Jie Chen, Zhijun Bao, Xiaona Hu BMC Gastroenterology .2025;[Epub] CrossRef Implementation of noninvasive liver disease screening tools in primary care Klaudia Nowak, Adrian Nowak, Aleksandra Jaboska, Anna Potaczek, Julia Salacha, Natalia Dardziska, Jakub Janczura Korean Journal of Family Medicine .2025
5-Amino-1MQ reduces white adipose tissue and body weight in preclinical obesity models without affecting appetite, highlighting its direct metabolic actions [8]
Non-alcoholic fatty liver disease and coexisting depression, anxiety and/or stress in adults: a systematic review and meta-analysis
GLP-1 drugs are diabetes medications with weight-loss effects prescribed to those struggling with obesity and Type 2 diabetes
